These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 33274491)

  • 21. An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs.
    Hosomi K; Fujimoto M; Ushio K; Mao L; Kato J; Takada M
    PLoS One; 2018; 13(10):e0204648. PubMed ID: 30300381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atropinic burden of prescriptions forms in patients with Alzheimer disease: a cross-sectional study in a French PharmacoVigilance Database.
    Montastruc F; Rouanet S; Gardette V; Rousseau V; Bagheri H; Montastruc JL
    Eur J Clin Pharmacol; 2015 Jul; 71(7):891-5. PubMed ID: 25991052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Alternative to Disproportionality: A Frequency-Based Method for Pharmacovigilance Data Mining.
    Jokinen JD; Lievano F; Scarazzini L; Truffa M
    Ther Innov Regul Sci; 2018 May; 52(3):294-299. PubMed ID: 29714535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating Overlap in Signals from EVDAS, FAERS, and VigiBase
    Vogel U; van Stekelenborg J; Dreyfus B; Garg A; Habib M; Hosain R; Wisniewski A
    Drug Saf; 2020 Apr; 43(4):351-362. PubMed ID: 32020559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database.
    Alexandre J; Salem JE; Moslehi J; Sassier M; Ropert C; Cautela J; Thuny F; Ederhy S; Cohen A; Damaj G; Vilque JP; Plane AF; Legallois D; Champ-Rigot L; Milliez P; Funck-Brentano C; Dolladille C
    Eur Heart J Cardiovasc Pharmacother; 2021 Jul; 7(4):312-320. PubMed ID: 32353110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase.
    Kröger E; Mouls M; Wilchesky M; Berkers M; Carmichael PH; van Marum R; Souverein P; Egberts T; Laroche ML
    Ann Pharmacother; 2015 Nov; 49(11):1197-206. PubMed ID: 26324356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of antipsychotic drugs: A systematic review of disproportionality analysis studies.
    Cepaityte D; Siafis S; Papazisis G
    Behav Brain Res; 2021 Apr; 404():113168. PubMed ID: 33581145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced tics: An observational postmarketing study.
    Touafchia D; Montastruc F; Lapeyre-Mestre M; Rousseau V; Chebane L; Revet A
    Hum Psychopharmacol; 2020 Jul; 35(4):e2734. PubMed ID: 32352603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Feasibility Study of Drug-Drug Interaction Signal Detection in Regular Pharmacovigilance.
    Hult S; Sartori D; Bergvall T; Hedfors Vidlin S; Grundmark B; Ellenius J; Norén GN
    Drug Saf; 2020 Aug; 43(8):775-785. PubMed ID: 32681439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data.
    Beex-Oosterhuis MM; Samb A; Heerdink ER; Souverein PC; Van Gool AR; Meyboom RHB; van Marum RJ
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):725-735. PubMed ID: 32378285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance.
    Zink RC; Huang Q; Zhang LY; Bao WJ
    Chin J Nat Med; 2013 May; 11(3):314-20. PubMed ID: 23725848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs and bruxism: A study in the World Health Organization's pharmacovigilance database.
    Montastruc JL
    Br J Clin Pharmacol; 2023 Dec; 89(12):3765-3768. PubMed ID: 37574820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced IgA vasculitis in children and adults: Revisiting drug causality using a dual pharmacovigilance-based approach.
    Rasmussen C; Tisseyre M; Garon-Czmil J; Atzenhoffer M; Guillevin L; Salem JE; Treluyer JM; Terrier B; Chouchana L
    Autoimmun Rev; 2021 Jan; 20(1):102707. PubMed ID: 33197572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems.
    Raschi E; Parisotto M; Forcesi E; La Placa M; Marchesini G; De Ponti F; Poluzzi E
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1098-1107. PubMed ID: 29174026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repurposing of drugs against bacterial infections: A pharmacovigilance-based data mining approach.
    Ohra S; Sharma R; Kumar A
    Drug Dev Res; 2024 Jun; 85(4):e22211. PubMed ID: 38807372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug induced stuttering: pharmacovigilance data.
    Trenque T; Morel A; Trenque A; Azzouz B
    Expert Opin Drug Saf; 2021 Mar; 20(3):373-378. PubMed ID: 33337944
    [No Abstract]   [Full Text] [Related]  

  • 37. Statin-induced myasthenia: A disproportionality analysis of the WHO's VigiBase pharmacovigilance database.
    Gras-Champel V; Batteux B; Masmoudi K; Liabeuf S
    Muscle Nerve; 2019 Oct; 60(4):382-386. PubMed ID: 31298743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse Events.
    Wang K; Wan M; Wang RS; Weng Z
    J Med Internet Res; 2016 Apr; 18(4):e76. PubMed ID: 27036325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced depressive symptoms: An update through the WHO pharmacovigilance database.
    Li J; Zelmat Y; Storck W; Laforgue EJ; Yrondi A; Balcerac A; Sommet A; Montastruc F
    J Affect Disord; 2024 Apr; 350():452-467. PubMed ID: 38244800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular safety of rapidly accelerated fibrosarcoma B-type and/or mitogen-activated extracellular signal-regulated kinase inhibitors: A mixed approach combining a meta-analysis and a pharmacovigilance disproportionality analysis.
    Dolladille C; Font J; Bejan-Angoulvant T; Zaman K; Sassier M; Ezine E; Stefan A; Plane AF; Legallois D; Milliez P; Parienti JJ; Alexandre J
    Arch Cardiovasc Dis; 2020; 113(6-7):420-432. PubMed ID: 32418884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.